Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T13:30:47.254Z.
Calculation as of: 2026-10-06T13:30:47.254Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ee881eee59918e8cff759d9372c22030baed04f147f6b571d3011c58a892a573
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Biomea Fusion, Inc.
Market Cap
$92.54M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$92.41M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.63M
Operating Cash Flow Yield
N/A
TTM Avg
5.92%
3Y Avg
6.70%
5Y Avg
6.29%
Market Cap
$88.21M
Operating Cash Flow Yield
6.68%
TTM Avg
4.42%
3Y Avg
3.83%
5Y Avg
2.85%
Market Cap
$87.96M
Operating Cash Flow Yield
30.38%
TTM Avg
24.07%
3Y Avg
48.72%
5Y Avg
43.33%
Market Cap
$87.88M
Operating Cash Flow Yield
N/A
TTM Avg
23.25%
3Y Avg
23.25%
5Y Avg
23.25%
Market Cap
$99.01M
Operating Cash Flow Yield
N/A
TTM Avg
6.71%
3Y Avg
6.71%
5Y Avg
6.71%
Market Cap
$101.52M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $92.54M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $92.41M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $88.97M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | N/A | 5.92% | 6.70% | 6.29% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 6.68% | 4.42% | 3.83% | 2.85% |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 30.38% | 24.07% | 48.72% | 43.33% |
| Equillium, Inc. (EQ)vs › | $87.88M | N/A | 23.25% | 23.25% | 23.25% |
| Anixa Biosciences, Inc. (ANIX)vs › | $99.01M | N/A | 6.71% | 6.71% | 6.71% |
| Korro Bio, Inc. (KRRO)vs › | $101.52M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $87.74M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
